Morgan Stanley lowered Pfizer (NYSE:PFE) price target to $44

By / / Morgan Stanley, Pfizer

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $45 to $44.

Scroll to Top